공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

유럽의 말초 정맥 카테터(PIVC) 시장 분석

European Market Report for Peripheral Intravenous Catheters 2017 - MedCore

리서치사 iData Research Inc.
발행일 2016년 11월 상품 코드 392568
페이지 정보 영문 165 Pages
가격
US $ 6,495 ₩ 7,262,000 PDF (Single User License) help
1명만 이용할 수 있는 라이선스입니다. DRM(디지털 저작권 관리시스템)장착 PDF파일로 Copy & Paste 는 가능하지만, 편집은 할 수 없습니다. 인쇄는 불가능합니다.
US $ 7,794 ₩ 8,715,000 PDF (Site License) help
동일 사업장 내에서 공유하여 이용할 수 있는 라이선스입니다. DRM(디지털 저작권 관리시스템)장착 PDF파일로 Copy & Paste 는 가능하지만, 편집은 할 수 없습니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 9,742 ₩ 10,893,000 PDF (Corporate License) help
동일 기업의 모든 분이 이용할 수 있는 글로벌 라이선스입니다. 이용 인원수에 제한은 없습니다. DRM(디지털 저작권 관리시스템)장착 PDF파일로 Copy & Paste 는 가능하지만, 편집은 할 수 없습니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.

주의 : 본 보고서는 DRM(디지털 저작권 관리 시스템)이 장착된 PDF 파일로, 라이선스에 따라 자료 이용 및 인쇄 등에 제약이 있을 수 있습니다. 자세한 내용은 라이선스 설명문( )을 참고하여 주시기 바랍니다.



유럽의 말초 정맥 카테터(PIVC) 시장 분석 European Market Report for Peripheral Intravenous Catheters 2017 - MedCore
발행일 : 2016년 11월 페이지 정보 : 영문 165 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

유럽 국가의 말초 정맥 카테터(이하 PIVC) 시장을 분석했으며, 시장 배경(관련 질환과 환자 수 등), 전체적인 시장 규모 추이와 전망(과거 4년간·향후 7년간), 제품 종류별·재료별 상세 동향 등의 조사·추산, 주요 기업의 개요와 제품 구성, 최근 기업간 경쟁 상황 등의 정보를 정리하여 전해드립니다.

1. 개요

2. 유럽의 혈관 액세스 디바이스·부속품 시장 : 개요

3. 경쟁 분석

4. 기업의 동향

5. 기업의 발전

6. 시술 건수

7. 분석 대상 시장

8. 주요 분석 업데이트 상황

9. 과거 버전

10. 분석 방법

  • 분석 범위
  • IDATA의 9단계 분석 방법

11. 질환 개요

  • 인체의 기본 구조
    • 인체의 혈관계
  • 혈관의 병태생리와 질환
    • 말기 신장 질환
    • 당뇨병

12. 제품 평가

  • 제품 포트폴리오
    • 말초 정맥 카테터(PIVC)
  • 규제상 문제와 리콜
  • 임상시험 : 말초 정맥 카테터(PIVC)
  • 제품 파이프라인

13. 각국 개요

  • 서론
    • 인구
    • 1인당 GDP
    • 가격지수
  • 독일
  • 프랑스
  • 영국
  • 이탈리아
  • 스페인
  • 베네룩스 국가
  • 북유럽 국가
  • 오스트리아
  • 스위스
  • 포르투갈

14. 말초 정맥 카테터(PIVC)

  • 서론
    • 안전 기능 포함 PIVC
      • 혈액 제어용·안전 기능 포함 PIVC
      • 비혈액 제어용·안전 기능 포함 PIVC
  • 수량 분석
    • PIVC 판매 개수 : 루멘(내강) 개수별
  • 시장 개요
  • 시장 분석과 예측
  • 수량 분석
    • 혈액 제어용·안전 기능 포함 PIVC 판매 개수 : 혈액 제어 메커니즘별
  • 시장 개요
  • 시장 분석과 예측
    • PIVC 시장 전체
    • 기존형 PIVC 시장
    • 안전 기능 포함 PIVC 시장 전체
      • 액티브 세이프티 방식
      • 패시브 세이프티 방식
      • 일체형·혈액 제어용·안전 기능 포함 PIVC
    • 정중 카테터 시장 전체
      • 기존형 정중 카테터 시장
      • 동력식·주입형 정중 카테터 시장
      • 일체형 정중 카테터 시장
  • 시장 촉진·억제요인
    • 시장성장 촉진요인
    • 시장성장 억제요인
  • 기업별 시장 점유율 분석

15. 약어 리스트

16. 부록 : 기업의 프레스 릴리스

17. 도표

KSA 16.12.06

The European PIVC market includes three segments: conventional PIVCs, safety PIVCs and midlines. The safety PIVC segment includes three sub-segments: active safety PIVCs, passive safety PIVCs and closed system PIVCs. The midline market comprises three sub-segments: conventional midlines, power-injectable midlines and all-in-one midlines. The PIVC markets in Europe were transformed in 2013 following the implementation of the directive by the Council of the European Union which aims to prevent needlestick injuries to healthcare workers. EU legislation as well as national legislation has put in place significant penalties for facilities that have a high incidence of needlestick injuries. To avoid the legal and health risks hospitals have been transitioning to the use of safety PIVCs. As a result, the conventional PIVC market will continue to decline over the forecast period. The value of the midline market is expected to increase strongly over the forecast period as adoption increases. The European peripheral intravenous catheters PIVC market includes three segments: conventional PIVCs, safety PIVCs and midlines. The safety PIVC segment includes three sub-segments: active safety PIVCs, passive safety PIVCs and closed system PIVCs. The midline market comprises three sub-segments: conventional midlines, power-injectable midlines and all-in-one midlines.

TABLE OF CONTENTS

TABLE OF CONTENTS

LIST OF FIGURES

LIST OF CHARTS

EXECUTIVE SUMMARY

EUROPEAN MARKET FOR VASCULAR ACCESS DEVICES AND ACCESSORIES OVERVIEW

COMPETITIVE ANALYSIS

MARKET TRENDS

MARKET DEVELOPMENTS

PROCEDURE NUMBERS

MARKETS INCLUDED

KEY REPORT UPDATES

VERSION HISTORY

RESEARCH METHODOLOGY

  • 1.1. RESEARCH SCOPE
  • 1.2. IDATA'S 9-STEP METHODOLOGY
    • Step 1: Project Initiation & Team Selection
    • Step 2: Prepare Data Systems and Perform Secondary Research
    • Step 3: Preparation for Interviews & Questionnaire Design
    • Step 4: Performing Primary Research
    • Step 5: Research Analysis: Establishing Baseline Estimates
    • Step 6: Market Forecast and Analysis
    • Step 7: Identify Strategic Opportunities
    • Step 8: Final Review and Market Release
    • Step 9: Customer Feedback and Market Monitoring

DISEASE OVERVIEW

  • 2.1. BASIC ANATOMY
    • 2.1.1. Human Vascular System
  • 2.2. VASCULAR PATHOLOGY AND DISORDERS
    • 2.2.1. Cancer
    • 2.2.2. End-Stage Renal Disease
    • 2.2.3. Diabetes

PRODUCT ASSESSMENT

  • 3.1. PRODUCT PORTFOLIOS
    • 3.1.1. Peripheral Intravenous Catheters
      • 3.1.1.1. Introduction
      • 3.1.1.2. Access Scientific
      • 3.1.1.2.1. POWERWAND®
      • 3.1.1.3. AngioDynamics
      • 3.1.1.3.1. BioFlo®
      • 3.1.1.4. Argon Medical
      • 3.1.1.4.1. First Midcath™
      • 3.1.1.4.2. L-Cath™
      • 3.1.1.5. B. Braun
      • 3.1.1.5.1. Introcan Safety®
      • 3.1.1.6. Becton Dickinson
      • 3.1.1.6.1. Nexiva™
      • 3.1.1.6.2. Saf-T-Intima™
      • 3.1.1.6.3. Autoguard™
      • 3.1.1.7. C.R. Bard
      • 3.1.1.7.1. AccuCath®
      • 3.1.1.7.2. PowerGlide®
      • 3.1.1.7.3. Bard® Poly
      • 3.1.1.7.4. Other Midline Offerings
      • 3.1.1.8. GaltNeedleTech
      • 3.1.1.8.1. Nexus™
      • 3.1.1.9. Medcomp
      • 3.1.1.9.1. Medcomp® Midline
      • 3.1.1.10. MediKit
      • 3.1.1.10.1. Supercath™
      • 3.1.1.11. Neo Medical
      • 3.1.1.11.1. PowerStick™
      • 3.1.1.11.2. Neo-Magic®
      • 3.1.1.12. Nipro Medical
      • 3.1.1.12.1. Nipro™ IV Catheter
      • 3.1.1.13. Retractable Technologies, Inc.
      • 3.1.1.13.1. VanishPoint®
      • 3.1.1.14. Smiths Medical
      • 3.1.1.14.1. ViaValve™
      • 3.1.1.14.2. PROTECTIV®
      • 3.1.1.14.3. ACUVANCE®
      • 3.1.1.14.4. Other PIVC offerings
      • 3.1.1.15. Tangent Medical
      • 3.1.1.15.1. NovaCath™
      • 3.1.1.16. Teleflex Medical
      • 3.1.1.16.1. ARROW®
      • 3.1.1.16.2. TwinCath®
      • 3.1.1.17. Terumo
      • 3.1.1.17.1. SurFlash®
      • 3.1.1.17.2. SURFLO®
      • 3.1.1.18. Vygon
      • 3.1.1.18.1. Leader-Flex™
  • 3.2. REGULATORY ISSUES AND RECALLS
    • 3.2.1. November 2015
    • 3.2.2. October 2015
    • 3.2.3. September 2015
    • 3.2.4. August 2015
    • 3.2.5. July 2015
    • 3.2.6. April 2015
    • 3.2.7. March 2015
    • 3.2.8. February 2015
    • 3.2.9. January 2015
    • 3.2.10. December 2014
    • 3.2.11. October 2014
    • 3.2.12. September 2014
    • 3.2.13. May 2014
    • 3.2.14. April 2014
    • 3.2.15. March 2014
    • 3.2.16. January 2014
    • 3.2.17. December 2013
    • 3.2.18. September 2013
    • 3.2.19. August 2013
    • 3.2.20. June 2013
    • 3.2.21. March 2013
    • 3.2.22. February 2013
    • 3.2.23. December 2012
    • 3.2.24. August 2012
    • 3.2.25. June 2012
    • 3.2.26. May 2012
    • 3.2.27. March 2012
    • 3.2.28. February 2012
    • 3.2.29. January 2012
  • 3.3. CLINICAL TRIALS
    • 3.3.1. Peripheral Intravenous Catheters
  • 3.4. PRODUCT PIPELINES
    • 3.4.1. Alliance Vascular Devices, LLC
      • 3.4.1.1. FreeHand Safety Huber Needle®
    • 3.4.2. AngioDynamics
      • 3.4.2.1. Celerity™ PICC Tip Confirmation System with Navigation
      • 3.4.2.2. Firefly
      • 3.4.2.3. BioFlo® PICC Line Extension
      • 3.4.2.4. BioFlo® Port Line Extension
      • 3.4.2.5. Next Generation BioFlo® PICC
      • 3.4.2.6. Next Generation BioFlo® Port
    • 3.4.3. Bluegrass Vascular Technologies, Inc.
      • 3.4.3.1. Surfacer® Inside-Out™ Access System
    • 3.4.4. C.R. Bard
      • 3.4.4.1. Chemical-Resistant PICCs
      • 3.4.4.2. Novel Advanced Material PICCs
      • 3.4.4.3. PowerGlide® Pro Midline
      • 3.4.4.4. AccuCath®
      • 3.4.4.5. Xenesis™ Acute Hemodialysis Catheter
      • 3.4.4.6. Site~Rite® 8 Ultrasound System
    • 3.4.5. M. C. Johnson
      • 3.4.5.1. PICC Securement Device
    • 3.4.6. Nipro Medical
      • 3.4.6.1. Shielding Safety Needle
      • 3.4.6.2. Safety Syringe
      • 3.4.6.3. Safety PIVC
    • 3.4.7. Parasol Medical
      • 3.4.7.1. Catheter Securement Device
    • 3.4.8. PAVmed Inc.
      • 3.4.8.1. NextCath™
    • 3.4.9. Phase One Medical
      • 3.4.9.1. Goldilocks™ Long Term Hemodialysis Catheter
      • 3.4.9.2. Triple-Lumen Symetrex™ Hemodialysis Catheter
    • 3.4.10. Prodigy Diabetes Care, LLC.
      • 3.4.10.1. Insulin Pen Needles
    • 3.4.11. Sharklet Technologies, Inc.
      • 3.4.11.1. Sharklet™ Central Venous Catheter
    • 3.4.12. Starboard Medical
      • 3.4.12.1. Catheter Securement Devices
    • 3.4.13. Teleflex Medical
      • 3.4.13.1. Arrow® Endurance™ Extended Dwell Peripheral Catheter System
      • 3.4.13.2. Tip Confirmation for CVCs, Chronic Hemodialysis Catheters & Ports
    • 3.4.14. Vascular Access Technologies, Inc.
      • 3.4.14.1. SAFECVAD™

COUNTRY PROFILES

  • 4.1. INTRODUCTION
    • 4.1.1. Population
    • 4.1.2. GDP Per Capita
    • 4.1.3. Price Index
  • 4.2. GERMANY
  • 4.3. FRANCE
  • 4.4. UNITED KINGDOM
  • 4.5. ITALY
  • 4.6. SPAIN
  • 4.7. BENELUX
  • 4.8. SCANDINAVIA
  • 4.9. AUSTRIA
  • 4.10. SWITZERLAND
  • 4.11. PORTUGAL

PERIPHERAL INTRAVENOUS CATHETER MARKET

  • 5.1. INTRODUCTION
    • 5.1.1. Safety PIVCs
      • 5.1.1.1. Blood Control Safety PIVCs
      • 5.1.1.2. Non-Blood Control Safety PIVCs
      • 5.1.1.2.1. Active Safety PIVCs
      • 5.1.1.2.2. Passive Safety PIVCs
  • 5.2. UNIT ANALYSIS
      • 5.2.1.1. Blood Control Safety Peripheral Intravenous Catheter Units Sold by Blood Control Mechanism
  • 5.3. MARKET OVERVIEW
  • 5.4. MARKET ANALYSIS AND FORECAST
    • 5.4.1. Total Peripheral Intravenous Catheter Market
    • 5.4.2. Conventional Peripheral Intravenous Catheter Market
    • 5.4.3. Total Safety Peripheral Intravenous Catheter Market
      • 5.4.3.1. Active Safety Peripheral Intravenous Catheter Market
      • 5.4.3.2. Passive Safety Peripheral Intravenous Catheter Market
      • 5.4.3.3. Integrated Blood Control Safety Peripheral Intravenous Catheter Market
    • 5.4.4. Total Midline Catheter Market
      • 5.4.4.1. Conventional Midline Catheter Market
      • 5.4.4.2. Power-Injectable Midline Catheter Market
      • 5.4.4.3. All-In-One Midline Catheter Market
  • 5.5. DRIVERS AND LIMITERS
    • 5.5.1. Market Drivers
    • 5.5.2. Market Limiters
  • 5.6. COMPETITIVE MARKET SHARE ANALYSIS

ABBREVIATIONS

APPENDIX: COMPANY PRESS RELEASES

LIST OF CHARTS

  • Chart 1-1: Vascular Access Device and Accessories Market by Segment, Europe, 2013-2023
  • Chart 1-2: Vascular Access Device and Accessories Market Overview, Europe, 2016 & 2023
  • Chart 4-1: Country Profile, Germany, 2016
  • Chart 4-2: Country Profile, France, 2016
  • Chart 4-3: Country Profile, United Kingdom, 2016
  • Chart 4-4: Country Profile, Italy, 2016
  • Chart 4-5: Country Profile, Spain, 2016
  • Chart 4-6: Country Profile, Benelux, 2016
  • Chart 4-7: Country Profile, Scandinavia, 2016
  • Chart 4-8: Country Profile, Austria, 2016
  • Chart 4-9: Country Profile, Switzerland, 2016
  • Chart 4-10: Country Profile, Portugal, 2016
  • Chart 5-1: Peripheral Intravenous Catheter Market by Segment, Europe, 2013-2023
  • Chart 5-2: Peripheral Intravenous Catheter Market by Segment, Europe, 2016
  • Chart 5-3: Peripheral Intravenous Catheter Market by Segment, Europe, 2023
  • Chart 5-4: Total Peripheral Intravenous Catheter Market, Europe, 2013-2023
  • Chart 5-5: Conventional Peripheral Intravenous Catheter Market, Europe, 2013-2023
  • Chart 5-6: Total Safety Peripheral Intravenous Catheter Market, Europe, 2013-2023
  • Chart 5-7: Active Safety Peripheral Intravenous Catheter Market, Europe, 2013-2023
  • Chart 5-8: Passive Safety Peripheral Intravenous Catheter Market, Europe, 2013-2023
  • Chart 5-9: Integrated Blood Control Safety Intravenous Catheter Market, Europe, 2013-2023
  • Chart 5-10: Total Midline Catheter Market, Europe, 2013-2023
  • Chart 5-11: Conventional Midline Catheter Market, Europe, 2013-2023
  • Chart 5-12: Power-Injectable Midline Catheter Market, Europe, 2013-2023
  • Chart 5-13: All-In-One Midline Catheter Market, Europe, 2013-2023
  • Chart 5-14: Leading Competitors, Peripheral Intravenous Catheter Market, Europe, 2016

LIST OF FIGURES

  • Figure 1-1: Vascular Access Device and Accessories Competitor Market Share Ranking by Segment, Europe, 2016(1 of 2)
  • Figure 1-2: Vascular Access Device and Accessories Competitor Market Share Ranking by Segment, Europe, 2016(2 of 2)
  • Figure 1-3: Companies Researched in this Report, Europe, 2016
  • Figure 1-4: Factors Impacting the Vascular Access Device and Accessories Market by Segment, Europe, 2016
  • Figure 1-5: Recent Events in the Vascular Access Device and Accessories Market, Europe, 2013-2016
  • Figure 1-6: Vascular Access Procedures Covered, Europe, 2016
  • Figure 1-7: Vascular Access Device and Accessories Markets Covered, Europe, 2016(1 of 3)
  • Figure 1-8: Vascular Access Device and Accessories Markets Covered, Europe, 2016(2 of 3)
  • Figure 1-9: Vascular Access Device and Accessories Markets Covered, Europe, 2016(3 of 3)
  • Figure 1-10: Key Report Updates
  • Figure 1-11: Version History
  • Figure 3-1: Class 2 Device Recall Medtronic
  • Figure 3-2: Class 2 Device Recall Smiths Medical
  • Figure 3-3: Class 2 Device Recall Arrow
  • Figure 3-4: Class 2 Device Recall Arrow
  • Figure 3-5: Class 2 Device Recall Covidien(Medtronic)
  • Figure 3-6: Class 2 Device Recall Arrow
  • Figure 3-7: Class 2 Device Recall Medline
  • Figure 3-8: Class 2 Device Recall Arrow
  • Figure 3-9: Class 2 Device Recall B. Braun
  • Figure 3-10: Class 3 Device Recall Bard Access
  • Figure 3-11: Class 2 Device Recall Covidien(Medtronic)
  • Figure 3-12: Class 2 Device Recall Bard Access
  • Figure 3-13: Class 2 Device Recall Bard Access
  • Figure 3-14: Class 2 Device Recall Medcomp & AngioDynamics
  • Figure 3-15: Class 2 Device Recall Bard Access
  • Figure 3-16: Class 2 Device Recall Arrow
  • Figure 3-17: Class 2 Device Recall Medcomp
  • Figure 3-18: Class 2 Device Recall Arrow
  • Figure 3-19: Class 2 Device Recall Arrow
  • Figure 3-20: Class 2 Device Recall Smiths Medical
  • Figure 3-21: Class 2 Device Recall PFM Medical
  • Figure 3-22: Class 2 Device Recall PFM Medical
  • Figure 3-23: Class 2 Device Recall Becton Dickinson
  • Figure 3-24: Class 2 Device Recall Arrow
  • Figure 3-25: Class 2 Device Recall Arrow
  • Figure 3-26: Class 2 Device Recall Navilyst Medical
  • Figure 3-27: Class 2 Device Recall Argon Medical
  • Figure 3-28: Class 2 Device Recall Arrow
  • Figure 3-29: Class 2 Device Recall Arrow
  • Figure 3-30: Class 2 Device Recall Arrow
  • Figure 3-31: Class 2 Device Recall Bard Access
  • Figure 3-32: Class 2 Device Recall Navilyst Medical
  • Figure 3-33: Class 2 Device Recall Bard Access
  • Figure 3-34: Class 2 Device Recall Smiths Medical
  • Figure 3-35: Class 2 Device Recall B. Braun
  • Figure 3-36: Class 2 Device Recall Smiths Medical
  • Figure 3-37: Class 2 Device Recall Access Scientific
  • Figure 3-38: Class 2 Device Recall Covidien(Medtronic)
  • Figure 3-39: Class 2 Device Recall Arrow
  • Figure 3-40: Class 2 Device Recall Bard Access
  • Figure 3-41: Class 2 Device Recall Becton Dickinson
  • Figure 3-42: Class 2 Device Recall Churchill Medical Systems, Inc. A Vygon Company
  • Figure 3-43: Class 2 Device Recall Bard Access
  • Figure 3-44: Class 2 Device Recall Churchill Medical Systems, Inc. A Vygon Company
  • Figure 3-45: Class 2 Device Recall Medcomp
  • Figure 3-46: Class 2 Device Recall Becton Dickinson
  • Figure 3-47: Class 3 Device Recall Bard Access
  • Figure 3-48: Class 2 Device Recall Medcomp
  • Figure 3-49: Class 1 Device Recall Arrow
  • Figure 3-50: Class 2 Device Recall Arrow
  • Figure 3-51: Class 2 Device Recall Vygon
  • Figure 3-52: Class 2 Device Recall Covidien(Medtronic)
  • Figure 3-53: Class 2 Device Recall Medcomp
  • Figure 3-54: Class 2 Device Recall Churchill Medical Systems, Inc. A Vygon Company
  • Figure 3-55: Class 2 Device Recall Christie Medical Holdings
  • Figure 3-56: Class 3 Recall Bard Access
  • Figure 3-57: Class 2 Device Recall AngioDynamics
  • Figure 3-58: Class 2 Device Recall Becton Dickinson
  • Figure 3-59: Class 2 Device Recall AngioDynamics
  • Figure 3-60: Class 2 Device Recall AngioDynamics
  • Figure 3-61: Class 3 Device Recall AngioDynamics
  • Figure 3-62: Class 2 Device Recall AngioDynamics
  • Figure 3-63: PICC and Midline Related Complications
  • Figure 3-64: Contribution of Ultrasound for Peripheral Intravenous Catheter Placement by Intensive Care Nurses
  • Figure 3-65: A Comparison of Accuvein to Standard Intravenous Access
  • Figure 3-66: Randomized, Controlled Study of Ultrasound-Guided Peripheral Venous Access
  • Figure 3-67: Pen Torch Transillumination: Shedding Light on Difficult Venepuncture
  • Figure 3-68: Ultrasound-guided Peripheral Vascular Access in Children
  • Figure 3-69: Preventing Delay of Care in Patient With Difficult IV Access
  • Figure 3-70: A Randomized Control Trial of Ultrasound Guided IV Access
  • Figure 3-71: Removal Peripheral Intravenous Catheters According to Clinical Signs
  • Figure 3-72: Clinical Investigation Acc. to MPG §23b
  • Figure 3-73: Evaluation of Accuvein® in Obese Patients
  • Figure 3-74: A Randomized, Open Label Study to Evaluate the Effectiveness of the MMT Initial Specimen Diversion Device
  • Figure 3-75: Technique for Successful Ultrasound-guided Peripheral Vascular Access
  • Figure 3-76: A Randomized Controlled Open Label Trial
  • Figure 3-77: A Prospective Feasibility Trial of AccuCath® 2.25" BC Intravascular Catheter System
  • Figure 3-78: The Use of a Topical Anesthetic Skin Refrigerant
  • Figure 3-79: A Randomized Controlled Trial to Demonstrate the Safety and Efficacy of the OptiVein® IV Catheter
  • Figure 3-80: Observational Study of the Sonic Window™ Handheld Ultrasound System
  • Figure 3-81: Near-Infrared Software Performance Study
  • Figure 3-82: A Randomized Controlled Trial To Compare The Initial Success Rate
  • Figure 3-83: A Clinical Assessment of an Ultrasound-guided Inserted Peripheral Intravenous Catheter
  • Figure 3-84: Ultrasound Guided Peripheral Intravenous Catheter Insertion
  • Figure 3-85: Nurse Peripheral Intravenous Catheter Insertion Success
  • Figure 5-1: Blood Control Safety Peripheral Intravenous Catheter Units Sold by Blood Control Mechanism, Europe, 2016
  • Figure 5-2: Peripheral Intravenous Catheter Market by Segment, Europe, 2013-2023(€M)
  • Figure 5-3: Peripheral Intravenous Catheter Market by Segment, Europe, 2013-2023(US$M)
  • Figure 5-4: Total Peripheral Intravenous Catheter Market, Europe, 2013-2023(€ and US$)
  • Figure 5-5: Units Sold by Country, Total Peripheral Intravenous Catheter Market, Europe, 2013-2023
  • Figure 5-6: Average Selling Price by Country, Total Peripheral Intravenous Catheter Market, Europe, 2013-2023(€)
  • Figure 5-7: Average Selling Price by Country, Total Peripheral Intravenous Catheter Market, Europe, 2013-2023(US$)
  • Figure 5-8: Market Value by Country, Total Peripheral Intravenous Catheter Market, Europe, 2013-2023(€M)
  • Figure 5-9: Market Value by Country, Total Peripheral Intravenous Catheter Market, Europe, 2013-2023(US$M)
  • Figure 5-10: Conventional Peripheral Intravenous Catheter Market, Europe, 2013-2023(€ and US$)
  • Figure 5-11: Units Sold by Country, Conventional Peripheral Intravenous Catheter Market, Europe, 2013-2023
  • Figure 5-12: Average Selling Price by Country, Conventional Peripheral Intravenous Catheter Market, Europe, 2013-2023(€)
  • Figure 5-13: Average Selling Price by Country, Conventional Peripheral Intravenous Catheter Market, Europe, 2013-2023(US$)
  • Figure 5-14: Market Value by Country, Conventional Peripheral Intravenous Catheter Market, Europe, 2013-2023(€M)
  • Figure 5-15: Market Value by Country, Conventional Peripheral Intravenous Catheter Market, Europe, 2013-2023(US$M)
  • Figure 5-16: Total Safety Peripheral Intravenous Catheter Market, Europe, 2013-2023(€ and US$)
  • Figure 5-17: Units Sold by Country, Total Safety Peripheral Intravenous Catheter Market, Europe, 2013-2023
  • Figure 5-18: Average Selling Price by Country, Total Safety Peripheral Intravenous Catheter Market, Europe, 2013-2023(€)
  • Figure 5-19: Average Selling Price by Country, Total Safety Peripheral Intravenous Catheter Market, Europe, 2013-2023(US$)
  • Figure 5-20: Market Value by Country, Total Safety Peripheral Intravenous Catheter Market, Europe, 2013-2023(€M)
  • Figure 5-21: Market Value by Country, Total Safety Peripheral Intravenous Catheter Market, Europe, 2013-2023(US$M)
  • Figure 5-22: Active Safety Peripheral Intravenous Catheter Market, Europe, 2013-2023(€ and US$)
  • Figure 5-23: Units Sold by Country, Active Safety Peripheral Intravenous Catheter Market, Europe, 2013-2023
  • Figure 5-24: Average Selling Price by Country, Active Safety Peripheral Intravenous Catheter Market, Europe, 2013-2023(€)
  • Figure 5-25: Average Selling Price by Country, Active Safety Peripheral Intravenous Catheter Market, Europe, 2013-2023(US$)
  • Figure 5-26: Market Value by Country, Active Safety Peripheral Intravenous Catheter Market, Europe, 2013-2023(€M)
  • Figure 5-27: Market Value by Country, Active Safety Peripheral Intravenous Catheter Market, Europe, 2013-2023(US$M)
  • Figure 5-28: Passive Safety Peripheral Intravenous Catheter Market, Europe, 2013-2023(€ and US$)
  • Figure 5-29: Units Sold by Country, Passive Safety Peripheral Intravenous Catheter Market, Europe, 2013-2023
  • Figure 5-30: Average Selling Price by Country, Passive Safety Peripheral Intravenous Catheter Market, Europe, 2013-2023(€)
  • Figure 5-31: Average Selling Price by Country, Pasive Safety Peripheral Intravenous Catheter Market, Europe, 2013-2023(US$)
  • Figure 5-32: Market Value by Country, Passive Safety Peripheral Intravenous Catheter Market, Europe, 2013-2023(€M)
  • Figure 5-33: Market Value by Country, Passive Safety Peripheral Intravenous Catheter Market, Europe, 2013-2023(US$M)
  • Figure 5-34: Integrated Blood Control Safety Peripheral Intravenous Catheter Market, Europe, 2013-2023(€ and US$)
  • Figure 5-35: Units Sold by Country, Integrated Blood Control Safety Peripheral Intravenous Catheter Market, Europe, 2013-2023
  • Figure 5-36: Average Selling Price by Country, Integrated Blood Control Safety Peripheral Intravenous Catheter Market, Europe, 2013-2023(€)
  • Figure 5-37: Average Selling Price by Country, Integrated Blood Control Safety Peripheral Intravenous Catheter Market, Europe, 2013-2023(US$)
  • Figure 5-38: Market Value by Country, Integrated Blood Control Safety Peripheral Intravenous Catheter Market, Europe, 2013-2023(€M)
  • Figure 5-39: Market Value by Country, Integrated Blood Control Safety Peripheral Intravenous Catheter Market, Europe, 2013-2023(US$M)
  • Figure 5-40: Total Midline Catheter Market, Europe, 2013-2023(€ and US$)
  • Figure 5-41: Conventional Midline Catheter Market, Europe, 2013-2023(€ and US$)
  • Figure 5-42: Power-Injectable Midline Market, Europe, 2013-2023(€ and US$)
  • Figure 5-43: All-In-One Midline Market, Europe, 2013-2023(€ and US$)
  • Figure 5-44: Drivers and Limiters, Peripheral Intravenous Catheter Market, Europe, 2016
  • Figure 5-45: Leading Competitors by Country, Peripheral Intravenous Catheter Market, Europe, 2016
  • Figure 7-1: Press Release Summary
Back to Top
전화 문의
F A Q